Bernhard Hirschel
Higher CNS penetration-effectiveness of long-term combination antiretroviral therapy is associated with better HIV-1 viral suppression in cerebrospinal fluid
Cusini A, Günthard H, Opravil M, Gutmann C, Zenger F, Klimkait T, Cavassini M, Gaudenz R, Hirschel B, Widmer N, Rohrbach J, Fux C, Ledergerber B, Decosterd L, Yerly S, Vernazza P, Swiss HIV Cohort Study. Higher CNS penetration-effectiveness of long-term combination antiretroviral therapy is associated with better HIV-1 viral suppression in cerebrospinal fluid. J Acquir Immune Defic Syndr 2013; 62:28-35.
01.01.2013Higher CNS penetration-effectiveness of long-term combination antiretroviral therapy is associated with better HIV-1 viral suppression in cerebrospinal fluid
01.01.2013J Acquir Immune Defic Syndr 2013; 62:28-35
Cusini Alexia, Günthard Huldyrich F, Opravil Milos, Gutmann Christine, Zenger Franziska, Klimkait Thomas, Cavassini Matthias, Gaudenz Roman, Hirschel Bernhard, Widmer Nicolas, Rohrbach Janine, Fux Christoph A, Ledergerber Bruno, Decosterd Laurent A, Yerly Sabine, Vernazza Pietro, Swiss HIV Cohort Study
Morbidity and aging in HIV-infected persons: the Swiss HIV cohort study
Hasse B, Weber R, Bernasconi E, Bertisch B, Cavassini M, Hirschel B, Battegay M, Furrer H, Ledergerber B, Swiss HIV Cohort Study. Morbidity and aging in HIV-infected persons: the Swiss HIV cohort study. Clin Infect Dis 2011; 53:1130-9.
13.10.2011Morbidity and aging in HIV-infected persons: the Swiss HIV cohort study
13.10.2011Clin Infect Dis 2011; 53:1130-9
Hasse Barbara, Weber Rainer, Bernasconi Enos, Bertisch Barbara, Cavassini Matthias, Hirschel Bernhard, Battegay Manuel, Furrer Hansjakob, Ledergerber Bruno, Swiss HIV Cohort Study
Cellular immune responses to HCV core increase and HCV RNA levels decrease during successful antiretroviral therapy
Rohrbach J, Rauch A, Klenerman P, Furrer H, Battegay M, Bernasconi E, Hoffmann M, Hirschel B, Günthard H, Keiser O, Telenti A, Gorgievski M, Gaudieri S, Hammond E, Harcourt G, Robinson N, Swiss HIV Cohort Study S. Cellular immune responses to HCV core increase and HCV RNA levels decrease during successful antiretroviral therapy. Gut 2010; 59:1252-1258.
26.07.2010Cellular immune responses to HCV core increase and HCV RNA levels decrease during successful antiretroviral therapy
26.07.2010Gut 2010; 59:1252-1258
Rohrbach Janine, Rauch Andri, Klenerman Paul, Furrer Hansjakob, Battegay Manuel, Bernasconi Enos, Hoffmann Matthias, Hirschel Bernhard, Günthard Huldrych F, Keiser Olivia, Telenti Amalio, Gorgievski Meri, Gaudieri Silvana, Hammond Emma, Harcourt Gillian, Robinson Nicola, Swiss HIV Cohort Study SHCS